Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status

Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status

Background: We studied the role of tumor-associated trypsin inhibitor (TATI) in serum and in tumor tissues among human papillomavirus (HPV)-positive and HPV-negative OPSCC patients. Materials and methods: The study cohort included 90 OPSCC patients treated at the Helsinki University Hospital (HUS),...

Full description

Bibliographic Details
Main Authors: Anni Sjöblom, Ulf-Håkan Stenman, Jaana Hagström, Lauri Jouhi, Caj Haglund, Stina Syrjänen, Petri Mattila, Antti Mäkitie, Timo Carpén
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
OPSCC
HPV
TATI
survival
Online Access:https://www.mdpi.com/2072-6694/13/11/2811

Internet

https://www.mdpi.com/2072-6694/13/11/2811

Similar Items